Astaxanthin slows down skeletal muscle atrophy in H22 tumor-bearing mice during sorafenib treatment by modulating the gut microbiota

Abstract

Astaxanthin supplementation altered the amino acid metabolism in tumor-bearing mice by modulating intestinal flora, thereby reducing the rate of skeletal muscle atrophy in tumor-bearing mice undergoing treatment.